PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Mar-2025 Alys Pharmaceuticals Announces Dosing of First Patient in Phase IIa Trial of ALY-101 for Alopecia Areata Alys Pharmaceuticals
27-Mar-2025 Kelso Pharma secures £140m of acquisition funding and appoints senior pharma executive as Non-Executive Director Kelso Pharma
27-Mar-2025 Santhera proposes Dr. Melanie Rolli as new member of Board of Directors Santhera Pharmaceuticals
27-Mar-2025 European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults Merck
27-Mar-2025 Evolva Holding SA shareholders elect Clearway representatives to the Board of Directors Evolva Holding SA
27-Mar-2025 RHÖN-KLINIKUM AG once again reports a successful financial year – CEO Prof. Kaltenbach leaves the Board of Management as planned RHÖN-KLINIKUM Aktiengesellschaft
27-Mar-2025 Grünenthal delivers exceptional financial results in 2024, powered by strategic growth and Valinor acquisition in the US Grünenthal GmbH
27-Mar-2025 Eckert & Ziegler: Record year 2024 with new all-time highs Eckert & Ziegler SE
27-Mar-2025 Marinomed focuses on growth after successful restructuring Marinomed Biotech AG
27-Mar-2025 Curatis: Umsatzwachstum von 30% im Vertrieb - dazu deutliche Ausweitung Patientenzielgruppe beim Lead-Projekt C-PTBE-01 Curatis Holding AG
27-Mar-2025 Formycon reports on a successful financial year 2024 with strong operational progress and continuous strengthening of its market position Formycon AG
26-Mar-2025  Abivax publishes financial reports with the French and U.S. securities regulatory agencies ABIVAX
26-Mar-2025 Over half of UK patients surveyed with hypoparathyroidism dissatisfied with treatment, finds largest ever UK survey of the UK hypoparathyroidism community Ascendis Pharma UK
26-Mar-2025 Secarna Pharmaceuticals to present positive new data on antisense oligonucleotide SECN-15 targeting NRP1 as monotherapy and in combination with immune checkpoint inhibitors at AACR Secarna Pharmaceuticals GmbH & Co. KG
26-Mar-2025 New Publication Reveals the Impact of Socioeconomic Factors on Health Outcomes and Importance of Self-Care Bayer
26-Mar-2025 New study results reinforce Tagrisso as the backbone therapy for EGFR-mutated lung cancer across stages and settings AstraZeneca
26-Mar-2025 Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older GSK
26-Mar-2025 Pleco Therapeutics Announces Positive Outcome of Pre-IND meeting with FDA for PTX-252 in Acute Myeloid Leukaemia Pleco Therapeutics
26-Mar-2025 ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility ONWARD Medical
26-Mar-2025 Chlamydia vaccine candidate granted fast track designation by the US FDA Sanofi